Centessa Pharmaceuticals Launches With a $250M Series A Financing
Centessa Pharmaceuticals (implementing an asset-centric model for drug R&D) launched with a $250M oversubscribed Series A financing from a group of blue-chip investors.
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.